Pre-TCRα Inhibitors
Chemical inhibitors of Pre-TCRα can disrupt its function through various mechanisms, focusing on different aspects of T-cell receptor signaling and development. Cyclosporin A and Ascomycin, for example, target calcineurin, a phosphatase critical for activating nuclear factors that turn on genes necessary for T-cell activation. By inhibiting calcineurin, these chemicals effectively prevent the downstream signaling required for Pre-TCRα's role in T-cell maturation. Similarly, FK506 (Tacrolimus) forms a complex with FKBP12 that inhibits calcineurin, thereby disrupting the T-cell activation process in which Pre-TCRα is involved. Rapamycin, through its interaction with FKBP12, inhibits mTOR, a kinase that is central to cell growth and proliferation, thereby indirectly diminishing the functional capabilities of Pre-TCRα by affecting the cellular environment in which it operates.
Further, Dasatinib, a broad-spectrum tyrosine kinase inhibitor, targets kinases such as Lck and Fyn, which are crucial for initiating TCR signaling cascades. By limiting the activity of these kinases, Dasatinib indirectly suppresses the function of Pre-TCRα. Likewise, PP2, an Src family kinase inhibitor, impedes the early signaling events in which Pre-TCRα participates, further illustrating how targeted kinase inhibition can influence Pre-TCRα activity. PKC inhibitors like Chelerythrine and Gö 6983 halt the function of enzymes necessary for propagating signals from the TCR complex; this disruption extends to the activity of Pre-TCRα. PI3K inhibitors, namely LY294002 and Wortmannin, obstruct the PI3K signaling cascade, which is essential for TCR-mediated functions, hence indirectly inhibiting Pre-TCRα. Lastly, PD98059, a MEK inhibitor, affects the MAPK/ERK pathway, which is activated after TCR engagement, suppressing the signal transduction pathways crucial for the functional utility of Pre-TCRα in developing T-cells.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A inhibits calcineurin, which is pivotal in T-cell activation via the T-cell receptor (TCR) pathway. As Pre-TCRα is involved in early TCR signaling, calcineurin inhibition by Cyclosporin A disrupts signaling events downstream of Pre-TCRα leading to its functional inhibition. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
FK506 binds to FKBP12, forming a complex that inhibits calcineurin. Since Pre-TCRα signaling requires calcineurin for downstream effects in T-cell activation, FK506 indirectly inhibits Pre-TCRα function by blocking calcineurin-mediated signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin binds to FKBP12 and inhibits mTOR, a kinase involved in T-cell proliferation and differentiation. By inhibiting mTOR, Rapamycin disrupts downstream signaling necessary for Pre-TCRα function in T-cell maturation and activation. | ||||||
Ascomycin | 104987-12-4 | sc-207303B sc-207303 sc-207303A | 1 mg 5 mg 25 mg | $37.00 $176.00 $322.00 | ||
Ascomycin inhibits calcineurin by binding to FKBP12, similar to FK506. The inhibition of calcineurin disrupts the signaling pathway necessary for Pre-TCRα-mediated T-cell activation, thus indirectly inhibiting Pre-TCRα function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor, and Src kinases are involved in early TCR signaling. Inhibition of Src kinases by PP2 therefore impairs the signal transduction pathway necessary for Pre-TCRα function in early T-cell development. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor, which includes Lck and Fyn, key kinases in TCR signaling. By hindering these kinases, Dasatinib indirectly inhibits Pre-TCRα signaling involved in T-cell development. | ||||||
Chelerythrine chloride | 3895-92-9 | sc-3547 sc-3547A | 5 mg 25 mg | $90.00 $317.00 | 17 | |
Chelerythrine is a potent inhibitor of protein kinase C (PKC), which is involved in signal transduction pathways of TCR. Inhibition of PKC results in disruption of signaling necessary for Pre-TCRα function, indirectly inhibiting its activity. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Gö 6983 is a pan-PKC inhibitor affecting multiple PKC isoforms crucial for TCR signaling. Inhibiting these PKC isoforms disrupts the signaling pathways that are necessary for Pre-TCRα function in T-cell development. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. PI3K signaling is involved in TCR-mediated activation pathways. By inhibiting PI3K, LY294002 disrupts the signaling cascade, leading to the functional inhibition of Pre-TCRα in T-cell activation and development. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another inhibitor of PI3K, which plays a role in TCR signaling. Inhibition of PI3K by Wortmannin leads to blockade of downstream signaling required for Pre-TCRα function in T-cell development and activation processes. | ||||||